EP2553095
A process for purifying vitamin K dependent proteins such as coagulation factor IX
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
30.3.2011EP published:
12.10.2016EP application number:
11713216.7
EPO information:
European Patent Register
Max expiry date:
29.3.2031
Title:
A process for purifying vitamin K dependent proteins such as coagulation factor IX
Timeline
Today
30.3.2011EP application
12.10.2016EP Publication
Owner
Name:
Octapharma AGAddress:
Seidenstrasse 2, 8853, Lachen, CH
Inventor
Name:
GILLJAM, GustavAddress:
142 42 Stockholm, SE
Name:
WINGE, StefanAddress:
120 50 Arsta, SE
Priority
Number:
282895 PDate:
16.4.2010Country:
US
Number:
10158511Date:
30.3.2010Country:
EP
Classification
Categories:
C12N 9/64